The Motley Fool. DATE Tuesday, June 3, 2025 at 4:30 p.m. ET Read More: Earn up to $845 cash back this year just by changing ...

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology <l ...

For Q1, the Madison Dividend Income Fund (class Y) returned +3.2%, which outperformed S&P 500 Index, Russell 1000 Value Index ...

Operator: Greetings, and welcome to the Eagle Point Income Company first quarter 2025 financial results call. At this time, all participants are in a listen-only mode.

Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other ...

RESTON, Va., June 02, 2025 (GLOBE NEWSWIRE) -- Science Applications International Corporation (NASDAQ: SAIC ), a premier Fortune 500 technology integrator driving our nation's digital transformation ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Total sales increased 6%, at the mid-point of guidance and on top of 11% last year Comparable store sales were flat, at the mid-point of guidance and on top of 2% last year Net income was $101 million ...